Table 2.
Distribution of PPARG Pro12Ala polymorphism in PCOS patients and controls
| Allele (%) | Genotype (%) | |||||||
|---|---|---|---|---|---|---|---|---|
| Groups | Pro N (%) | Ala N (%) | P | OR 95% CI | Pro/Pro N (%) | Pro/Ala N (%) | Ala/Ala N (%) | P |
| PCOS (n=100) | 162 (81) | 38(19) | 0. 01 | 2.01 (1.17-3.47) | 68 (70) | 26 (26) | 6 (6) | 0.03 |
| Controls (n=120) | 215 (89.58) | 25 (10.14) | 96 (80) | 23 (19.66) | 1 (0.8) | |||
aχ2 test, PPARG, peroxisome proliferator-activated receptor gamma gene; PCOS, polycystic ovary syndrome.